| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 3.470 | 16.730 | 38.599 | 59.299 | 87.439 | 97.298 |
| Total Income - EUR | - | - | - | - | 3.470 | 16.744 | 42.099 | 60.074 | 88.370 | 98.311 |
| Total Expenses - EUR | - | - | - | - | 178 | 3.441 | 11.459 | 15.683 | 26.225 | 39.938 |
| Gross Profit/Loss - EUR | - | - | - | - | 3.292 | 13.303 | 30.640 | 44.391 | 62.144 | 58.373 |
| Net Profit/Loss - EUR | - | - | - | - | 3.188 | 12.837 | 29.619 | 43.808 | 61.284 | 55.499 |
| Employees | - | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Rigyn Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 607 | 8.500 | 8.412 | 50.591 | 36.787 |
| Current Assets | - | - | - | - | 3.376 | 15.581 | 32.229 | 46.805 | 37.097 | 41.358 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 1.104 | 1.572 | 3.201 | 36.072 | 34.583 | 39.550 |
| Cash | - | - | - | - | 2.272 | 14.010 | 29.028 | 10.733 | 2.514 | 1.808 |
| Shareholders Funds | - | - | - | - | 3.230 | 16.006 | 39.949 | 43.857 | 61.332 | 55.547 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 146 | 321 | 790 | 9.987 | 26.239 | 22.518 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 1.372 | 821 | 272 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Rigyn Med S.r.l.